RA
CEMI

Royce & Associates’s Chembio diagnostics, Inc. CEMI Stock Holding History

Royce & Associates’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-135,800
Closed -$49K – 999
2022
Q3 		$49K Hold
135,800
– – ﹤0.01% 923
2022
Q2 		$88K Hold
135,800
– – ﹤0.01% 923
2022
Q1 		$111K Sell
135,800
-178,553
-57% -$167K ﹤0.01% 947
2021
Q4 		$358K Sell
314,353
-177,100
-36% -$361K ﹤0.01% 916
2021
Q3 		$1.23M Hold
491,453
– – 0.01% 797
2021
Q2 		$1.46M Hold
491,453
– – 0.01% 804
2021
Q1 		$1.73M Hold
491,453
– – 0.01% 779
2020
Q4 		$2.33M Hold
491,453
– – 0.02% 697
2020
Q3 		$2.39M Sell
491,453
-92,889
-16% -$440K 0.03% 647
2020
Q2 		$1.9M Sell
584,342
-590,974
-50% -$5.61M 0.02% 675
2020
Q1 		$6.02M Buy
1,175,316
+183,824
+19% +$744K 0.08% 320
2019
Q4 		$4.52M Buy
991,492
+375,874
+61% +$1.83M 0.04% 512
2019
Q3 		$3.77M Buy
615,618
+146,465
+31% +$873K 0.03% 546
2019
Q2 		$2.86M Hold
469,153
– – 0.03% 631
2019
Q1 		$2.6M Hold
469,153
– – 0.02% 664
2018
Q4 		$2.65M Buy
469,153
+150,000
+47% +$1.11M 0.02% 648
2018
Q3 		$3.35M Buy
319,153
+19,800
+7% +$213K 0.02% 699
2018
Q2 		$3.32M Buy
299,353
+84,000
+39% +$756K 0.02% 706
2018
Q1 		$1.72M Buy
215,353
+112,953
+110% +$903K 0.01% 880
2017
Q4 		$840K Buy
102,400
+80,500
+368% +$545K 0.01% 997
2017
Q3 		$136K Hold
21,900
– – ﹤0.01% 1078
2017
Q2 		$132K Buy
+21,900
New +$137K ﹤0.01% 1090

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates's CEMI Position: Q4 2022 in Review

Royce & Associates sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2022, closing a stake of 135,800 shares — an estimated $49K sold.

Royce & Associates first reported a position in CEMI in Q2 2017 and held it in 22 quarters. The position peaked at $6.02M in Q1 2020. 38 funds tracked by Wall St. Rank hold CEMI as of Q4 2022.

  • Royce & Associates reported no remaining Chembio diagnostics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Royce & Associates sold 135,800 Chembio diagnostics, Inc. shares in Q4 2022, an estimated $49K.
  • Royce & Associates first reported a position in Chembio diagnostics, Inc. in Q2 2017 and held it in 22 quarters.
  • Royce & Associates's Chembio diagnostics, Inc. position peaked at $6.02M in Q1 2020.
  • 38 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2022.

Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.